Every Form 4 that ProAssurance Corporation (PRA) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow PRA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PRA filings page.
PROASSURANCE CORP director Maye Head Frei reported a disposition of shares in connection with the company’s merger. On June 26, 2026, 31,298 shares of Common Stock were disposed of to the issuer at $25.00 per share, leaving no shares reported as owned after the transaction.
This transaction reflects the closing of the merger in which a subsidiary of The Doctors Company combined with ProAssurance, with ProAssurance continuing as a wholly owned subsidiary. At the merger’s effective time, each outstanding common share, including deferred director shares, was cancelled and converted into the right to receive $25.00 in cash, subject to applicable withholding taxes.
PROASSURANCE CORP director Scott C. Syphax disposed of 25,184 shares of Common Stock at $25.00 per share as part of a cash merger. The shares were cancelled and converted into the right to receive the cash merger consideration, leaving him with zero directly owned shares after the transaction.
PROASSURANCE CORP director Bruce D. Angiolillo disposed of 35,652 shares of common stock in connection with the closing of the merger with The Doctors Company. Each share was cancelled at the effective time of the merger and converted into the right to receive $25.00 in cash, leaving him with no reported remaining shares.
PROASSURANCE CORP director Katisha Terrell Vance disposed of 34,159 shares of common stock in connection with the company’s merger. The shares were cancelled and converted into a right to receive $25.00 per share in cash at the merger’s effective time.
The transaction is reported as a disposition to the issuer tied to the completion of the merger with The Doctors Company, after which ProAssurance became a wholly owned subsidiary. Following this cash-out event, the filing shows Vance with 0 shares of ProAssurance common stock directly held.
ProAssurance Corporation director Staci Pierce reported a disposition of common stock tied to the company’s merger. On June 26, 2026, 10,621 shares of ProAssurance common stock were cancelled and converted into cash at $25.00 per share under the merger agreement with The Doctors Company.
This transaction was a disposition to the issuer as part of the merger closing, not an open-market trade. Following the cash-out, Pierce no longer holds any ProAssurance common stock.
PROASSURANCE CORP Chief Financial Officer Dana S. Hendricks reported dispositions of equity in connection with the company’s merger with The Doctors Company. On June 26, 2026, 45,392 shares of common stock were cancelled and converted into the right to receive $25.00 per share in cash under the merger terms.
The filing also shows dispositions of outstanding unvested restricted stock units representing 11,778, 7,686 and 23,720 shares of common stock, which automatically vested at the merger’s effective time and were cancelled for cash based on the same $25.00-per-share merger consideration. Following these merger-related transactions, the Form 4 reflects zero shares and RSUs held for this reporting person.
Shook Kevin Merrick reported disposition transactions in this Form 4 filing.
PROASSURANCE CORP executive Kevin Merrick Shook, President of a subsidiary, reported that all of his equity in the company was cashed out in connection with the merger with The Doctors Company. On June 26, 2026, 53,237 shares of common stock were cancelled and converted into the right to receive $25.00 per share in cash.
On the same date, three awards of restricted stock units covering 11,778, 7,686 and 23,720 shares of common stock were also cancelled. Under the merger terms, these outstanding, unvested RSUs automatically vested and entitled him to a cash payment based on the $25.00 per share merger consideration. Following these transactions, the filing shows he no longer holds ProAssurance common stock or RSUs.
ProAssurance Corporation executive Robert David Francis reported dispositions of all his equity in connection with the company’s merger with The Doctors Company. A total of 31,196 shares of common stock were cancelled at $25.00 per share in cash as merger consideration.
In addition, several blocks of time-based and performance-based restricted stock units, each representing the right to receive one share of common stock, automatically vested at the merger’s effective time, were cancelled, and entitled him to receive cash based on the same $25.00-per-share merger consideration. Following these actions, the filing shows no remaining common stock or restricted stock units held directly by Francis.
PROASSURANCE CORP director COBARRUBIAS FABILOA reported a disposition of 25,184 shares of Common Stock back to the issuer at $25.00 per share. This reflects how their equity was treated when ProAssurance merged with The Doctors Company.
According to the merger terms, a subsidiary of The Doctors Company merged into ProAssurance, leaving ProAssurance as a wholly owned subsidiary. At the merger’s effective time, each outstanding share of ProAssurance common stock was cancelled and converted into the right to receive $25.00 in cash, subject to taxes. Deferred stock awards held under the ProAssurance Corporation Director Deferred Stock Compensation Plan were similarly converted into cash based on the same $25.00 per share merger consideration. Following this cash-out treatment, the filing shows the director with zero shares of common stock remaining.
PROASSURANCE CORP director Samuel A. Di Piazza Jr. reported dispositions of common stock tied to the closing of the company’s merger with The Doctors Company. He surrendered a total of 44,952 shares of common stock to the issuer at $25.00 per share, receiving cash instead of shares.
Footnotes explain that, at the merger’s effective time, all outstanding common shares and director deferred stock awards were cancelled and converted into the right to receive the Merger Consideration of $25.00 per share in cash. Following these transactions, Di Piazza no longer holds ProAssurance common stock.
PROASSURANCE CORP director Richard J. Bielen reported a disposition of 10,621 shares of Common Stock in connection with the company’s merger. Each share of Common Stock outstanding immediately before the effective time of the merger was cancelled and converted into the right to receive $25.00 in cash.
The 10,621 shares, including director deferred stock awards, were converted into a cash payment based on this $25.00 per share merger consideration, and Bielen’s reported direct Common Stock holdings became zero following the transaction.
PROASSURANCE CORP executive Noreen Dishart reported dispositions tied to the company’s merger with The Doctors Company. On June 26, 2026, she disposed of 27,868 shares of Common Stock in a transaction with the issuer at $24.47 per share, reducing her direct common stock holdings to zero.
In connection with the same merger, her outstanding time-based and performance-based restricted stock units (RSUs) covering 5,987, 9,175, and 18,477 underlying shares of Common Stock were cancelled. Under the merger terms, each share of Common Stock was converted into the right to receive $25.00 per share in cash, and vested RSUs became entitled to equivalent cash payments, leaving her with no remaining RSU or derivative holdings in PRA.
PROASSURANCE CORP executive Jeffrey Patton Lisenby reported the cash-out of his equity holdings in connection with the company’s merger. He disposed of 98,066 shares of common stock in a disposition to the issuer at $25.00 per share, consistent with the merger terms. In addition, several blocks of restricted stock units, each representing one share of common stock, were cancelled at the merger’s effective time and converted into cash based on the same $25.00 per-share merger consideration. Following these transactions, the filing shows no remaining common stock or RSU holdings for the reporting person.
PROASSURANCE CORP President & CEO Rand Edward Lewis Jr reported dispositions in connection with the closing of the company’s merger with The Doctors Company. On June 26, 2026, all 293,945 shares of common stock he held were cancelled and converted into the right to receive $25.00 per share in cash under the merger terms.
The filing also shows 47,529, 29,665 and 95,714 outstanding restricted stock units, each representing one share of common stock, were cancelled at the effective time of the merger. These vested and entitled him to cash equal to the number of underlying shares multiplied by the same $25.00 per share merger consideration. Following these transactions, no common stock or RSUs are shown as beneficially owned.
ProAssurance Corporation executive Noreen Dishart, Executive VP and Chief HR Officer, exercised restricted stock units into common shares and had a portion withheld for taxes. On February 25, 2026, she converted 4,588, 5,987, and 3,101 restricted stock units into the same number of common shares at a stated price of $24.47 per share. To cover tax obligations, 5,917 common shares were disposed of as a tax-withholding transaction, leaving her with 27,740 shares of ProAssurance common stock held directly.
ProAssurance Corporation executive Robert David Francis reported multiple equity award transactions. On February 25, 2026, he exercised Restricted Stock Units that converted into 3,226, 8,765, and 5,890 shares of common stock at a stated price of $24.47 per share. A separate transaction shows 7,711 common shares disposed of to cover tax obligations, a tax-withholding disposition rather than an open-market sale. After these transactions, he directly owned 31,196 common shares, along with multiple tranches of RSUs that vest in annual installments from 2024 through 2029 under the company’s 2014 and 2024 equity incentive plans.
PROASSURANCE CORP Chief Financial Officer Dana S. Hendricks reported multiple equity award transactions involving restricted stock units and common shares on February 25, 2026. Hendricks exercised several batches of restricted stock units, converting 5,890, 7,686, and 3,981 restricted stock units into the same number of common shares, all reported at a transaction price of $24.47 per share for the common stock entries.
In a separate transaction coded F, Hendricks disposed of 7,623 common shares at a reported price of $24.47 per share to satisfy exercise price or tax obligations. Following these transactions, Hendricks directly owned 45,603 shares of common stock and maintained several outstanding restricted stock unit awards with reported balances of 23,720, 7,686, and 11,778 units, which vest in pro rata installments over future years if employment conditions are met.
ProAssurance Corp President and CEO Edward Rand Jr reported multiple equity award transactions on common stock and restricted stock units. On February 25, 2026, he exercised several batches of restricted stock units into common shares at $24.47 per share and increased his direct common stock holdings.
In connection with these equity events, 30,436 common shares were disposed of to cover tax liabilities, a non–open-market, tax-withholding transaction. Footnotes explain that each restricted stock unit represents a right to one common share that generally vests in equal one-third installments over three-year periods between 2024 and 2029, with accelerated vesting upon death, disability, certain employment terminations, or Compensation Committee action.
ProAssurance Corporation subsidiary president Kevin Merrick Shook reported multiple equity award transactions. On February 25, 2026, he exercised several batches of Restricted Share Units (RSUs), converting them into ProAssurance common stock at a reference price of $24.47 per share, and then disposed of 7,587 shares to cover tax obligations. After these transactions, he directly owned 53,447 shares of common stock.
The RSUs come from the ProAssurance Corporation 2014 Equity Incentive Compensation Plan and generally vest in equal one‑third installments over three years across award cycles spanning 2024–2029, subject to continued employment. Vesting accelerates upon death, disability, or certain employment terminations defined as Good Reason, and RSUs are settled in a mix of shares and cash approximately equal to taxes.
ProAssurance Corp executive Jeffrey Patton Lisenby, Executive Vice-President and General Counsel, exercised restricted stock units into common shares of ProAssurance on February 25, 2026. He acquired 17,557 shares of common stock through derivative exercises at a reference price of $24.47 per share, with 7,615 shares disposed of to cover tax liabilities. Following these transactions, he directly owned 98,286 shares of common stock. The related restricted stock units were granted under the company’s 2014 and 2024 equity incentive plans and generally vest in equal annual installments over three years, with potential accelerated vesting upon death, disability, Good Reason termination, or Compensation Committee action.
ProAssurance Corporation reported an equity compensation award to a senior executive. Executive Vice-President, Secretary & General Counsel Jeffrey Patton Lisenby received 23,720 Restricted Stock Units (RSUs) on January 7, 2026 at a cash price of $0 per unit.
Each RSU represents a contingent right to one share of ProAssurance common stock under the 2014 Equity Incentive Compensation Plan. The new award will vest pro rata in one‑third increments in 2027, 2028 and 2029, assuming continued employment, with accelerated vesting upon death, disability, certain employment terminations for “Good Reason,” or as approved by the compensation committee. Settlement will be in ProAssurance shares plus cash approximately equal to applicable taxes. The filing also lists existing RSU holdings of 17,668, 15,372 and 3,981 units from prior grants.
ProAssurance Corporation’s President & CEO, Rand Edward Lewis Jr, reported an equity award in the form of restricted stock units. On January 7, 2026, he received 95,714 Restricted Stock Units (RSUs) at a price of $0 per unit, all held directly.
Each RSU gives a contingent right to one share of ProAssurance common stock under the company’s equity incentive plans. The newly reported RSUs tied to the 2014 Equity Incentive Compensation Plan are scheduled to vest in three equal installments in 2027, 2028, and 2029, as long as he remains employed with ProAssurance or its subsidiaries. Vesting can accelerate if his employment ends because of death, disability, Good Reason under his employment agreement, or by action of the Compensation Committee. When RSUs vest, they will be settled partly in shares and partly in cash to cover estimated taxes.
ProAssurance Corporation disclosed that its Chief Financial Officer, Dana S. Hendricks, received an award of 23,720 Restricted Stock Units (RSUs) on 01/07/2026. Each RSU represents a contingent right to receive one share of ProAssurance common stock under the ProAssurance Corporation 2014 Equity Incentive Compensation Plan.
According to the award terms, these RSUs will vest pro rata in one-third increments in each of the years 2027, 2028 and 2029, as long as the CFO remains continuously employed by ProAssurance or a subsidiary through each vesting date. Vesting will accelerate if employment ends due to death, disability or Good Reason, or by action of the Compensation Committee. The RSUs will be settled in shares of common stock and in cash, with the cash portion approximately equal to federal, state and local taxes.
ProAssurance Corporation reported an equity compensation grant to Kevin Merrick Shook, President of a subsidiary. On January 7, 2026, he received 23,720 Restricted Stock Units (RSUs) under the ProAssurance Corporation 2014 Equity Incentive Compensation Plan. These RSUs vest pro rata in one-third increments in 2027, 2028 and 2029, conditioned on his continued employment, with vesting accelerating upon death, disability, Good Reason as defined in his employment agreement, or action by the Compensation Committee. The RSUs will be settled in shares of ProAssurance common stock and cash to cover estimated taxes. Following this award, he directly holds this new RSU grant and additional RSUs from prior awards, including 17,668, 15,372 and 3,981 units.
ProAssurance Corporation granted equity compensation to a senior executive through restricted stock units. On January 7, 2026, Executive VP/Chief HR Officer Noreen Dishart received 18,477 Restricted Stock Units (RSUs) at a price of $0 per unit under the ProAssurance Corporation 2014 Equity Incentive Compensation Plan. Each RSU represents the right to receive one share of ProAssurance common stock plus a cash amount approximately equal to applicable taxes.
The newly granted RSUs are scheduled to vest in three equal installments in 2027, 2028, and 2029, subject to continued employment, with accelerated vesting upon death, disability, certain qualifying employment terminations, or action by the Compensation Committee. The filing also shows previously granted RSUs with post-transaction balances of 13,763, 3,101, and 11,974 units, all held directly.
ProAssurance Corporation reported an insider equity award for executive Francis Robert David, President, Healthcare Professional Liability. On January 7, 2026, he received 23,720 Restricted Stock Units (RSUs) at a price of $0 per unit under the ProAssurance Corporation 2014 Equity Incentive Compensation Plan.
Each RSU represents the right to receive one share of ProAssurance common stock. The new award will vest in three equal annual installments in 2027, 2028, and 2029, as long as he remains continuously employed with ProAssurance or a subsidiary. Vesting can accelerate if employment ends due to death, disability, Good Reason as defined in his employment agreement, or by action of the Board’s Compensation Committee. Settlement will be in ProAssurance shares plus a cash amount approximately equal to applicable taxes.